87 related articles for article (PubMed ID: 25327441)
1. Involvement of retrotransposon L1 in stemness and cellular plasticity.
Apostolou P; Toloudi M; Chatziioannou M; Kourtidou E; Mimikakou G; Vlachou I; Chlichlia A; Papasotiriou I
Cell Commun Adhes; 2015; 22(1):1-7. PubMed ID: 25327441
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
3. LINE-1 induces hTERT and ensures telomere maintenance in tumour cell lines.
Aschacher T; Wolf B; Enzmann F; Kienzl P; Messner B; Sampl S; Svoboda M; Mechtcheriakova D; Holzmann K; Bergmann M
Oncogene; 2016 Jan; 35(1):94-104. PubMed ID: 25798839
[TBL] [Abstract][Full Text] [Related]
4. Activation of LINE-1 Retrotransposon Increases the Risk of Epithelial-Mesenchymal Transition and Metastasis in Epithelial Cancer.
Rangasamy D; Lenka N; Ohms S; Dahlstrom JE; Blackburn AC; Board PG
Curr Mol Med; 2015; 15(7):588-97. PubMed ID: 26321759
[TBL] [Abstract][Full Text] [Related]
5. Exploring stemness gene expression and vasculogenic mimicry capacity in well- and poorly-differentiated hepatocellular carcinoma cell lines.
Lirdprapamongkol K; Chiablaem K; Sila-Asna M; Surarit R; Bunyaratvej A; Svasti J
Biochem Biophys Res Commun; 2012 Jun; 422(3):429-35. PubMed ID: 22580004
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional disruption by the L1 retrotransposon and implications for mammalian transcriptomes.
Han JS; Szak ST; Boeke JD
Nature; 2004 May; 429(6989):268-74. PubMed ID: 15152245
[TBL] [Abstract][Full Text] [Related]
7. L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers.
Gavert N; Vivanti A; Hazin J; Brabletz T; Ben-Ze'ev A
Mol Cancer Res; 2011 Jan; 9(1):14-24. PubMed ID: 21123622
[TBL] [Abstract][Full Text] [Related]
8. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.
Chiou SH; Wang ML; Chou YT; Chen CJ; Hong CF; Hsieh WJ; Chang HT; Chen YS; Lin TW; Hsu HS; Wu CW
Cancer Res; 2010 Dec; 70(24):10433-44. PubMed ID: 21159654
[TBL] [Abstract][Full Text] [Related]
9. BRACHYURY confers cancer stem cell characteristics on colorectal cancer cells.
Sarkar D; Shields B; Davies ML; Müller J; Wakeman JA
Int J Cancer; 2012 Jan; 130(2):328-37. PubMed ID: 21365650
[TBL] [Abstract][Full Text] [Related]
10. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X
Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715
[TBL] [Abstract][Full Text] [Related]
11. Biochemical Approaches to Study LINE-1 Reverse Transcriptase Activity In Vitro.
Viollet S; Doucet AJ; Cristofari G
Methods Mol Biol; 2016; 1400():357-76. PubMed ID: 26895064
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of ZNF746 suppresses invasion and epithelial to mesenchymal transition in H460 non-small cell lung cancer cells.
Kim B; Sohn EJ; Jung JH; Shin EA; You OH; Im J; Kim SH
Oncol Rep; 2014 Jan; 31(1):73-8. PubMed ID: 24145959
[TBL] [Abstract][Full Text] [Related]
13. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
[TBL] [Abstract][Full Text] [Related]
14. ZEB2 upregulates integrin α5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells.
Nam EH; Lee Y; Park YK; Lee JW; Kim S
Carcinogenesis; 2012 Mar; 33(3):563-71. PubMed ID: 22227038
[TBL] [Abstract][Full Text] [Related]
15. TGFβ1 secreted by cancer-associated fibroblasts induces epithelial-mesenchymal transition of bladder cancer cells through lncRNA-ZEB2NAT.
Zhuang J; Lu Q; Shen B; Huang X; Shen L; Zheng X; Huang R; Yan J; Guo H
Sci Rep; 2015 Jul; 5():11924. PubMed ID: 26152796
[TBL] [Abstract][Full Text] [Related]
16. Effect of downregulation of ZEB1 on vimentin expression, tumour migration and tumourigenicity of melanoma B16F10 cells and CSCs.
Dou J; He X; Liu Y; Wang Y; Zhao F; Wang X; Chen D; Shi F; Wang J
Cell Biol Int; 2014 Apr; 38(4):452-61. PubMed ID: 24339410
[TBL] [Abstract][Full Text] [Related]
17. Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition.
Feng Q; Moran JV; Kazazian HH; Boeke JD
Cell; 1996 Nov; 87(5):905-16. PubMed ID: 8945517
[TBL] [Abstract][Full Text] [Related]
18. Increased CD13 expression reduces reactive oxygen species, promoting survival of liver cancer stem cells via an epithelial-mesenchymal transition-like phenomenon.
Kim HM; Haraguchi N; Ishii H; Ohkuma M; Okano M; Mimori K; Eguchi H; Yamamoto H; Nagano H; Sekimoto M; Doki Y; Mori M
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S539-48. PubMed ID: 21879266
[TBL] [Abstract][Full Text] [Related]
19. Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness.
Wu K; Ning Z; Zeng J; Fan J; Zhou J; Zhang T; Zhang L; Chen Y; Gao Y; Wang B; Guo P; Li L; Wang X; He D
Cell Signal; 2013 Dec; 25(12):2625-33. PubMed ID: 24012496
[TBL] [Abstract][Full Text] [Related]
20. Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR‑145.
Ren D; Wang M; Guo W; Zhao X; Tu X; Huang S; Zou X; Peng X
Int J Oncol; 2013 Apr; 42(4):1473-81. PubMed ID: 23404342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]